UFP Technologies, Inc. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission File Number: 001-12648 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended MARCH 31, 2024 (Exact name of registrant as specified in its charter) Delaware 04-2314970 | | | on whic ...

EXHIBIT 99.1 About UFP Technologies, Inc. UFP Technologies Announces Record Q1 Results NEWBURYPORT, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $12.7 million or $1.64 per diluted common share outstanding for its first quarter ended March 31, 2024, compared to net income of $9.7 million or $1.27 per diluted common share outstanding for the first quart ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 001-12648 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 04-2314970 (State or oth ...

NEWBURYPORT, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of engineered solutions primarily for the medical market, today reported net income of $44.9 million or $5.83 per diluted common share outstanding for its year ended December 31, 2023, compared to net income of $41.8 million or $5.45 per diluted common share outstanding for 2022. Net sales for 2023 were $400.1 million, 13.1% higher than 2022 sales of $353.8 million. EXHIBIT 99.1 UF ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended SEPTEMBER 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission File Number: 001-12648 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 04-2314970 (State or ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended JUNE 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission File Number: 001-12648 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 04-2314970 (State or othe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended MARCH 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission File Number: 001-12648 UFP Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 04-2314970 (State or oth ...

Financial Performance - Net sales increased by 71.5% to $353.8 million for the year ended December 31, 2022, from $206.3 million in 2021, driven by a 116.0% increase in sales to the Medical market and an organic sales increase of approximately 24.0%[95][98]. - Gross margin improved to 25.5% for the year ended December 31, 2022, up from 24.8% in 2021, despite a 5.5% increase in material and labor costs[95][99]. - Operating income and net income for the year ended December 31, 2022, increased by 161.1% and 163.1%, respectively, despite challenges such as raw material and labor shortages[95]. Expenses and Costs - Selling, General, and Administrative Expenses (SG&A) rose approximately 55.3% to $45.8 million for the year ended December 31, 2022, but decreased as a percentage of sales to 12.9% from 14.3% in 2021[100]. - The Company incurred approximately $1.0 million in acquisition-related costs for the year ended December 31, 2022[102]. - The fair value of contingent consideration liabilities recognized at December 31, 2022, totaled approximately $14.6 million, with an expense of approximately $9.8 million recorded for the year[103]. - Net interest expense increased to approximately $2.8 million for the year ended December 31, 2022, primarily due to interest on funds drawn for acquisitions[106]. Cash Flow and Investments - Net cash provided by operations for the year ended December 31, 2022, was approximately $17.7 million, driven by net income of approximately $41.8 million[118]. - Net cash provided by investing activities was approximately $1.3 million, primarily from the sale of Molded Fiber and the Georgetown manufacturing facility[120]. - Net cash used for financing activities was approximately $25.9 million, primarily due to payments on the revolving line of credit of approximately $60 million and principal payments of long-term debt of approximately $4 million[121]. - The Company generated cash of approximately $17.7 million from operations during the year ended December 31, 2022, but future cash generation cannot be guaranteed[131]. Debt and Financing - As of December 31, 2022, the Company had approximately $55 million in borrowings outstanding under the Second Amended and Restated Credit Agreement, with an applicable interest rate of approximately 5.2%[125]. - The Second Amended and Restated Credit Agreement matures on December 21, 2026, and includes a secured term loan of $40 million and a revolving credit facility of up to $90 million[123]. - Future maturities of long-term debt total approximately $55 million, with $4 million due in 2023 and $24 million due in 2026[127]. - The Company uses interest-rate-related derivative instruments to manage exposure to changes in interest rates on variable-rate debt instruments[128]. - The Company is subject to a minimum fixed-charge coverage financial covenant and a maximum total funded debt to EBITDA financial covenant under the Second Amended and Restated Credit Agreement[124]. Future Plans - The Company plans to continue adding capacity to enhance operating efficiencies in its manufacturing plants throughout fiscal 2023[132]. - The Company anticipates that future business expansion will be financed through existing resources, cash flow from operations, and the revolving credit facility[133]. - At December 31, 2022, the Company had approximately $9.4 million available for future repurchases of its common stock under the stock repurchase program[134]. Asset Sales - The Company sold Molded Fiber Technology for approximately $31.5 million, resulting in a net gain of approximately $15.7 million recorded in 2022[104].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended SEPTEMBER 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission File Number: 001-12648 UFP Technologies, Inc. Securities registered pursuant to Section 12(b) of the Act: | | | on which registere ...

Welcome Investors September 21, 2022 S TECHNOLOGIES Forward Looking Statements Certain statements in this presentation may be considered "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or the Company's future financial or operating performance and may be identified by words such as "may," "should," "expect," "intend," "will," "estimate," "anticipat ...